Postprandial Hypoglycemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2026-02-20
Clinical Trial Update: Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes [Phase 2]
Clinical trial evaluating empagliflozin and anakinra for postprandial hypoglycemia in patients with prediabetes has been withdrawn.